RT Journal Article SR Electronic T1 Absolute quantification and degradation evaluation of SARS-CoV-2 RNA by droplet digital PCR JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.06.24.20139584 DO 10.1101/2020.06.24.20139584 A1 Curtis J. Mello A1 Nolan Kamitaki A1 Heather de Rivera A1 Steven A. McCarroll YR 2020 UL http://medrxiv.org/content/early/2020/06/26/2020.06.24.20139584.abstract AB Quantifying SARS-CoV-2 infectivity, formulating well-calibrated public-health policy, and managing the safety of workplaces would all be facilitated by precise measurement of the extent to which SARS-CoV-2 RNA is present in an intact form in biological specimens and human environments. We describe assays that use digital PCR in nanoliter droplets (droplet digital PCR) to measure these properties. Such assays could be broadly deployed to inform COVID-19 epidemiology, measure symptomatic and asymptomatic infectivity, and help manage the safety of environments in which people live, move, and work.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by Harvard Medical School with no external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:No IRB approval was sought for this study as we utilized synthetic SARS-CoV-2 RNA to validate our work.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData for this study is included in figures and tables in the manuscript.